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ABSTRACT
Case studies are a standard approach to medicine. A physician needs the outcomes of a drug,
situationally relevant to a particular patient. We propose a system for patient outcomes utiliz-
ing computational semantics, which effectively digests message groups. Filtering identifies
personal comments, by eliminating useless messages. Clustering groups similar topics from
different messages, by statistical overlap with specified terms. Summarizing labels the clusters
so content can be quickly digested. We implemented a prototype system with these functions
for mining health messages. Our methods do not require extensive training or dictionaries,
while enabling users to specify custom topics for digesting. This system has been tested with
sample messages from our unique dataset from Yahoo! Groups, containing 12M personal mes-
sages from 27K public groups in Health and Wellness. Evaluated results show high quality of
labeled clustering, promising an effective automatic system for discovering useful information
across large volumes of health information.
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CHAPTER 1
Introduction
Online discussions now play an essential role in people’s daily life. When a person plans to
buy an electronic product, she would like to view other customers’ reviews from shopping
websites. When a user tries to trade on some specific stock, she would like to know other
traders’ comments from online stock discussion board. Online discussions in specific area are
so important, because they collect different users’ recent experiences. Though subjective, they
reflect the most direct and comprehensive opinions from actual people using actual products.
When it comes to healthcare, the situation is similar: online bulletin boards and chat groups,
such as Yahoo! Groups1 and WebMD2, offer patients and doctors a good platform to discuss
health problems, e.g., diseases and drugs, diagnosis and treatment. Case studies are a standard
approach to medicine. A physician wants to know how well a drug works, what its outcomes
are, including side-effects. A patient wants to know the outcomes with similar patients, who
did better and who did worse, under what conditions.
Online medical discussions have limitations preventing users from effectively digesting the
information. If you use a drug name as the entry to search the database, there are usually thou-
sands of comments or reviews returned. The outcomes need to be integrated and summarized
in a targeted fashion. We propose an interactive system for health messages, which addresses
the following problems:
1http://groups.yahoo.com/
2http://www.webmd.com/
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1. Filtering: Medical discussions contain a huge number of irrelevant messages. For ex-
ample, some users will quote news articles, while advertisements will also display on the
discussion board. The discussions must be filtered, so that only the user comments from
actual persons remain.
2. Clustering: Unlike product reviews, medical discussion messages are unstructured, i.e.,
each comment talks about several topics, in just one piece of plain text. The messages
must be partitioned into parts, and parts on similar topics from different messages must
be grouped together to form a coherent view of all the information available from all the
people on each topic.
3. Summarizing: Each group contains multiple messages about the topic under discus-
sion. And each dataset contains multiple topics, e.g., among all the messages discussing
Meridia, some deal with weight loss, some with side effect, some with expensive price.
The groups must accordingly be labeled effectively so that users can quickly find the
desired messages within the desired topics.
Our system for patient outcomes solves all of these problems to effectively digest message
groups. Filtering transforms the database into personal health messages, by deleting news
and adverts. Clustering groups similar topics from sentences appearing in different messages,
where the topic categories can be specified manually by an expert or identified automatically
by the system. Summarizing labels the groups so that their content can be quickly digested, by
giving a sample sentence from the clustered messages or a series of generated phrases. These
steps propose to re-organize the information of medical online discussions in a practical way.
We have implemented a prototype system for text mining of health messages. This system
has been tested with sample messages from our unique dataset from Yahoo! Groups, which
contains 12M personal messages from 27K public groups in Health and Wellness. This out-
comes research utilizes deeper processing of natural language, such as SVM and PLSA, than
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our previous study on drug reactions with this dataset[1]. Our methods do not require exten-
sive training nor do they require dictionaries. In addition, they enable users to specify their
own topics for digesting. Thus these methods are very general and very powerful.
The rest of this paper is organized as follows: Chapter 2 summarizes the related work and
techniques. Chapter 3 defines the problem, the key concepts and the symbols in principle.
Chapter 4 describes the algorithm and implementation of our approaches. Chapter 5 provides
experimental results indicating the high accuracy and usefulness of the system. Finally, we
conclude the paper in Chapter 6 and outline the future work in Chapter 7.
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CHAPTER 2
Related Work
Our paper focuses on detect the outcome of a specific drug from users’ messages. Richardson
et al. [2] identified four aspects: P ,E,C,O as the key aspects of clinical information: P stands
for Patient-problem: what are the patient characteristics (e.g. age range, gender, etc.)? What
is the primary condition or disease? E stands for Exposure-intervention: what is the main
intervention (e.g. drug, treatment, duration, etc.)? C stands for Comparison: what is the
exposure compared to (e.g. placebo, another drug, etc.)? O stands for Outcome: what are the
clinical outcomes (e.g. healing, morbidity, side effects, etc.)? These elements are known as the
PECO elements.
However, it is very difficult to extract the PECO elements from medical information using
the traditional entity extraction technique due to the complexities and unsureness of the medical
information, even in the formal literature. A lot of evaluation work are based on manually
labeled data, such as Nie’s work [3].
A lot of applications utilized the medical formal literature to extract and integrate useful
information. Such applications include: generating text summaries [4], topic modeling [5],
mining predictive rules [6], etc. Our paper uses informal medical messages which are gen-
erated by multiple online users. Compared with the formal one, informal messages are more
unstructured, noisy, and difficult to process.
Also some researchers paid attention to the informal medical messages. For instance, Crain
et al. [7] worked on consumer medical search by using Yahoo! Answer health messages,
while Chee’s work tracked users’ sentiment regarding particular drugs [1] and did information
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visualization [8] based on Yahoo! Medical Group Messages. Using the same dataset as [1, 8],
we do a comprehensive information extraction task and apply a series of data mining and
information retrieval techniques, which are mainly introduced below.
Probabilistic latent semantic analysis (PLSA) [9] has been applied to many text mining
problems with good results. Researchers use this model to solve problems such like opinion
intergration [10], sentiment analysis [11], web search and mining [12], etc. To the best of our
knowledge, Lu’s work [10] which focuses on automatically integrating opinions from product
reviews using the semi-supervised PLSA model is close to our motivation, though we have
different data source and purpose.
After generating multiple topics from a bench of texts, labeling each topic with semantic
terms or phrases would help to understand each topic intuitively. From the survey we find that
Mei’s work [13] on automatic labeling could be applied on top of the results of our clustered
medical outcomes.
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CHAPTER 3
Problem Definition
For one particular drug, we collect all the related health messages from Yahoo! Groups, de-
noted as M , in which N is the set of all the news, C is the set of all the user comments (our
target input), and A is the set of advertisements. Clearly, we have M = N ∪ C ∪ A.
After successfully extracting C, we split it into a set of sentences, denoted as D. Each
sentence d ∈ D is a comment unit, which would potentially present one side of outcomes. Our
target goal is to group all the comments into m meaningful outcome clusters O1, O2, ...Om,
given the collection D.
Here are several key concepts to be introduced:
1. Expert comment ei: To better cluster the outcomes, semi-supervised PLSA model
would be applied. Expert comments aim to offer the prior knowledge for PLSA and
key points for each Oi. For each Oi we have one expert comment ei. Compared with
the user comments, the expert comment should be more well-written and semantically
vertical to each other. Thus we collect all the set of expert comments E (formed by
e1, e2, ...en, n < m), for each drug, from a professional drug information website1.
2. Similar opinion Oi sim and Supplementary opinion Oi sup: Each outcome Oi consists
of a group of comment units Di and one expert comment ei. Some of the comments
represent similar opinion with ei, which form Oi sim. Others reflect different opinions
from ei, though they still talk about the same topic. We call such collection Oi sup. Here
1http://www.drugs.com/
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Oi sup can be split into several sub-clusters, where each represents one of the different
opinions.
3. Outcome Label li: For each topic (as a cluster or sub-cluster) we generated, since it con-
sists of multiple sentences, it is difficult to understand the meaning of the topic directly.
In addition to selecting one representative sentence for each cluster, we automatically
generate a set of phrases li for each cluster, which would semantically interpret the topic.
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CHAPTER 4
Methodology
From Chapter 1, we know that there are three main steps:
Filtering: The input is the whole collection M . We will separate it into three classes: C, N
and A. C is our target, and we need to filter out N and A.
Clustering: Outcome selection and integration: Given C and n expert comments e1, e2, ...en,
we would generate m (m > n) clusters O1, O2, ...Om. Each refers to one discriminative out-
come and can be further split into similar opinion Oi sim and supplementary opinion Oi sup.
Note the reason why m > n is we want to generate some outcomes beyond any expert com-
ments, called extra comments.
Summarizing: For each semantic topic (as the form of a cluster or sub-cluster), we would
automatically generate a set of phrases li to label the topic.
We will discuss the methodology of these steps in details.
4.1 Step 1: Filtering the Messages
After roughly observing several messages, we can separate them into three groups:
• News (N ): When users are discussing about their health conditions, they may directly
share or quote one article from news. The content of a news article is related to the drug,
mainly about the latest FDA approvement or scientific discovery. Although containing
useful information, it is too long and full of irrelevant information, which is difficult to
extract the useful part. So we will eliminate this group of messages.
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• Comments (C): User comments are the most informative part in the whole collection
M since they reflect users’ actual feelings and experiences on drugs – the outcomes.
They have proper lengths and most of the parts can be directly extracted. This group of
messages is our target and also the input of Step 2.
• Ads (A): Since Yahoo! Group is an open discussion board, it contains a huge number of
advertisements, sent by individuals or robots. They are useless to the project and should
be eliminate also. They are usually very short, and repeatable (entirely repeatable or
sentence-base repeatable) which is a good feature to distinguish A from others.
Table 4.1 shows a snippet of each kind of messages, which are extracted from the real data.
Table 4.1: Message Examples
...FDA officials could not
maintain their iron grip in
an effort to suppress evidence
of far reaching lethal effects
of Vioxx when their actions
were in full public view. FDA
officials were forced to lift the
roadblocks they had put in Dr.
David Graham’s way. They
gave him approval...
(a). News
...I have been on Meridia for
14 months and have lost 93
pounds. I have about 30
pounds to go to my goal but
I feel great! I too heard all
the horror stories from others
about the negatives of taking
Meridia even from my family
and friends. But I do believe
in it...
(b). Comment
...Everything is 70% off for this week
only!
Get for mens health
Buy Valium for CHEAP
Get Xanax for Anti Anxiety.
Buy Meridia online for weight loss...
(c). Ad
To classify such three groups of messages, we apply SVM classification [14] to split all the
messages into three classes (N , C, A). Support vector machines (SVM) are a set of related
9
supervised learning methods that analyze data and recognize patterns, used for classification.
It has relatively high accuracy and can handle high-dimensional data. It is a good solution to
distinguish the messages and filter the useless ones.
To apply SVM classification in our project, there are five main steps:
1. Manually label some examples as comments, news, and ads, called training data.
2. Select useful features from the training data.
3. Transfer each message into a high-dimensional vector, where each dimension refers to
one feature.
4. Train a SVM classifier on the training data, which automatically studies the weight for
each dimension and find the most discriminative margin among the different groups.
5. Test the unlabeled data by the SVM classifier.
The most essential step is the feature selection, we find the following features can be con-
sidered:
• Word distribution: term frequency of each messages.
• Basic statistics of text: message length, the number of paragraphes, etc.
• Word uniqueness: the ratio of the number of unique words to the message length. (We
find ads have a low ratio since the content is always repeatable).
• Some special features: e.g. how many “I” are there in one message. (user comments
possibly contain many), etc.
We train a 3-class SVM classifier [15] and test on the real data. The results show a high
accuracy. We will introduce the experiment details in Section 5.2.
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4.2 Step 2: Clustering – Outcome Selection and Integration
To group the comments into reasonable and discriminative clusters, where each cluster repre-
sents one main outcome of the drug. Semi-supervised PLSA [9] model is applied. We would
introduce the model first and then describe the integration process.
4.2.1 PLSA Model
In the PLSA model, we consider each document in the collectionD is generated from a mixture
of m+ 1 multinomial component models. One component model is the background model θB
that absorbs non-discriminative (i.e., meaningless) words and the rest are the m latent theme
topic models (saying Θ = {θ1, θ2, ...θm}) that are estimated by Equation 4.5 via the Expecta-
tion Maximization (EM) algorithm [16], a method for finding maximum likelihood estimates
of parameters in statistical models, all the parameters and results can be computed and updated
using the following formulas:
p(zd, w, j) =
(1− λB)pi(n)d,j p(n)(w|θj)
λBp(w|θB) + (1− λB)
∑k
j′=1 pi
(n)
d,j′p
(n)(w|θ′j)
(4.1)
p(zd, w,B) =
λBp(w|θB)
λBp(w|θB) + (1− λB)
∑k
j′=1 pi
(n)
d,j′p
(n)(w|θ′j)
(4.2)
pi
(n+1)
d,j =
∑
w∈V c(w, d)p(zd,w,j)∑
j′
∑
w∈V c(w, d)p(zd,w,j′)
(4.3)
p(n+1)(w|θj) =
∑
d∈D c(w, d)p(zd,w,j)∑
w′∈V
∑
d∈D c(w, d)p(zd,w′,j)
(4.4)
p(n+1)(w|θj) =
∑
d∈D c(w, d)p(zd,w,j)∑
w′∈V
∑
d∈D c(w, d)p(zd,w′,j)
(4.5)
To better cluster m aspects, we can enroll some prior knowledge by extending the basic
PLSA to incorporate a conjugate prior defined base on expert comments e1, e2, ..., en (i.e.,
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semi-supervised). For each outcome cluster Oi (1 ≤ i ≤ n), since we have already acquire the
expert comment ei, we can build a unigram language model {p(w|ei)} and interpret it into the
above formula, after several computing, Formula 4.5 turns into the following format:
p(n+1)(w|θj) =
∑
d∈D c(w, d)p(zd,w,j) + µp(w|ej)∑
w′∈V
∑
d′∈D c(w
′, d′)p(zd,w′,j) + µ
(4.6)
Note, for the cluster Oi (n < i ≤ m), there is no prior knowledge since we aim to find some
extra outcome topics rather than the experts.
4.2.2 Integration Progress
To build these m meaningful clusters by applying semi-supervised PLSA model, there are
several steps described below:
1. Build the prior knowledge. For each cluster Oi (1 ≤ i ≤ n), we have already acquired
an expert comment ei. Based on it, we estimate p(w|ei) by Maximum Likelihood as the
prior estimator. Here only adjectives, adverbs, verbs and nouns are considered in the
estimator since they are the terms which express the opinions.
2. Given such priors and the set of the comment unitsD, we could estimate the topic models
{θ1, θ2, ...θm} by the formulas in Section 4.2.1.
3. For each comment unit d ∈ D, we assign it to the most suitable cluster by the following
formula:
a
j
rgmaxp(d|θj) = a
j
rgmax
∑
w∈V
c(w, d)p(w|θj) (4.7)
4. Now in each cluster Oi, there are a couple of assigned comment units. For the cluster
which has a prior expert comment, we would separate them into Similar opinion Oi sim
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and Supplementary opinion Oi sup, by applying the semi-supervised PLSA model to cre-
ate two clusters with ei as one cluster’s prior knowledge.
5. In each Supplementary opinion Oi sup, it may contain different opinions and we apply
a basic PLSA model without any prior knowledge to create several meaningful sub-
opinions.
6. Now for each opinion, we select one sentence from the assigned comment units to rep-
resent such topic, which is easier for users to understand compared to topic models, and
associated with the supporting value (the size of the clusters).
We apply the above process on the real data and get meaningful results. We will show the result
and evaluate it in Section 5.3 and 5.4.
4.3 Step 3: Summarizing: Automatic Labeling
From Mei’s analysis [13], a good label for text should be understandable to the users, and could
capture the semantic meaning of the topic. Compared with sentences or individual words, a
phrase is coherent and concise for a user to read and understand. Avoiding manually labeling
each topic i, we can use an automatic labeling technique to generate a set of phrases li for each
semantic cluster. The main steps are as below:
1. Candidate label generation: The first step is to generate a collection of labels as the for-
mat of phrases. There are several methods, such as: chunking/parsing, Ngram testing,
etc. We use the Ngram testing to generate bigram phrases from the original sentence clus-
ters. We generate the most significant bigrams using the N-gram Statistics Package [17],
and use T-test to choose the ones which have the highest T-Score [18].
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2. Relevance scoring: Intuitively, a phrase which contains more important words in the
topic, would be seen as a good label. Here, the importance can be defined as the high
frequency of the word in the topic model. We use p(w|θ) to present the word distribution
of the topic θ, and the relevance score of a candidate phrase l = w0w1...wk could be
defined as:
Score = log
p(l|θ)
p(l)
=
∑
0≤i≤k
log
p(wi|θ)
p(wi)
(4.8)
3. Choosing li: After computing the score for each candidate label, we choose the ones
which have the top score, forming the set of labels of one cluster i.
In Section 5.5, for each drug, we automatically generate semantic labels for each similar opin-
ion Oi sim, as well as each extra outcome cluster without expert comments.
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CHAPTER 5
Experiments and Results
5.1 Data and Setup
We utilize health messages from Yahoo! Groups to build the SVM classifier, topic model and
test. The forum consists of 27, 290 groups and over 12, 519, 807 messages totally, spanning
seven years and multiple topics. The data is also applied in Chee’s work [1].
All the experiment is running on a 4TB-disk, 4GB-RAM, and 10-core server.
5.2 Filtering Result
Since we build a drug-based system, for each drug, we need to select the related messages
which form the whole collection M , and then spite it into three categories: N , C (target) and
A by applying the SVM classification method.
We choose three drugs as our investigation objectives: Meridia(diet drug), Vioxx(arthritis
drug) and Tysabri(multiple sclerosis drug), all of which have been withdrawn by FDA since
serious side efforts. However, it would be an advantage for our task since many clear-stated
outcomes would be described by users.
We randomly choose 141 messages from the collection of Meridia as the training data.
After manually labeling them we acquire 33 pieces of news, 37 comments and 71 pieces of
ads. From this we can see the personal health messages are really dirty – a huge number of
data is useless and should be eliminated.
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We choose the features according the Section 4.1 and get an 800−dimensional vector space
(most of the dimensions represent the word distribution). Following the steps of the SVM
classification, we transfer the data into vector form, test the unlabeled data, and chunk the
messages in C into sentences. Tabel 5.1 shows the statistics of the classification.
Table 5.1: The result of the SVM classification
Drug Name # of messages # of user comments # of commend units
Meridia 672 160 3752
Vioxx 3799 748 19236
Tysabri 919 56 1317
To test the robust and accuracy of our SVM classifier, first we test the training data back
and get 139 correct labels and 2 incorrect ones. Second we randomly choose 60 messages from
the test pool (20 for each drug) and manually label them as the standard, we get 56 correct
labels and 4 incorrect ones. The accuracy rate is 93.3%. Such results show our SVM classifier
can successfully filter out useless messages and acquire the target group C.
5.3 Clustering Result
Now we have the set of comment units D for each drug, according to the semi-supervised
PLSA model introduced before, we would generate the outcome results for each drug.
Table 5.2 and Table 5.3 show the clustering results with expert comments, and the extra
outcomes without prior knowledge, respectively, for the drug of Meridia. From Table 5.2,
eventually we build 9 clusters for Meridia, where each of them focuses on one meaningful
semantic outcome. For example, Outcome ID 1 mainly talks about the topic of Meridia’s
use. From the expert comment e1 we know taking Meridia may help to lose weight. And
16
298 comments support the similar opinion. While others express different opinions although
the same topic: weight and function. For example, 77 comments say the wish to lose weight.
70 comments talk about another function of Meridia. From such one row, we would easily
get the general knowledge and statistics of user comments on this outcome of Meridia. This
information is scattered in the huge amount of messages and impossible to integrate by hand
without such system.
Besides the 9 outcomes for Meridia which cover the main aspects that user may be in-
terested in: effectiveness, why taking it, how much and how long to take it, various of side
efforts, and the price, we also find 3 extra outcomes which are not mentioned in the expert
comments. For example, Outcome ID 12 shows the appreciation of the usefulness of Yahoo!
Health Group. These outcomes would make the whole condition of one particular drug more
completely, rather than just following the professional’s.
Read the information from both of the tables, one may find the result of our system would
effectively collect and integrate the drug-based information and display it in a well-readable
way.
Table 5.4 and Table 5.5 show the corresponding clustering results for Vioxx. And Table 5.6
and Table 5.7 refer to the condition of Tysabri. From the results we can see our system would
not only work well for one drug, but also fit other drugs.
One of the advantages of the PLSA model against other simple statistic methods relies on
its capacity of capturing the coherence of terms (e.g., appositive, synonym) the PLSA model is
able to detect such connection between the two comments which contain since they share the
similar contexts. Take one of the Meridia’s outcome (ID 2) as an example, the expert comment
is “Take Meridia exactly as prescribed by your doctor and follow the directions on your pre-
scription label.”. The 133 similar sentences contain not only “i am seriously considering going
to a new doctor” which capture the word “doctor” exactly, but also “tracy you might ask your
17
Table 5.2: The outcome results for Meridia with expert comments
ID Keywords Expert comment Similar Opinions Supplementary Opinions
1 lose
pounds
Meridia is used together with
diet and exercise to treat
obesity. It helps to lose pounds
in weeks.
[s=298] i have been on meridia for 14
months and have lost 93 pounds
[s=77] i just know that i want the extra weight
off of me.
[s=60] and i worked out with weights 3 times
per week
[s=70] evidently maybe the drugs really
bombed out her immune system
2 doctor
prescrip-
tion
Take Meridia exactly as
prescribed by your doctor and
follow the directions on your
prescription label.
[s=133] the doctor gave me a
prescription for 2 month and we will
see if we can not get at least a good start
on weightloss for me
[s=105] i called the medical hotline at meridia
a couple of days ago to ask a few questions
[s=61] i simply asked a short question
3 taken
daily, food
Meridia is usually taken once
daily. Meridia can be taken
with or without food.
[s=140] i am on 10 mg once per day at
lunch time just because it s easier for
me to remember
[s=67] i scrutinized every food label to ensure
that there were no sugars
[s=72] however i do still have food cravings
4 2 years Meridia should not be takenfor longer than 2 years.
[s=228] i was just going to get another
prescription after taking it for 2 years
[s=65] it s the week before and the week during
that i feel the thyroid symptoms the worse
[s=62] yesterday marked the beginning of
month 11 for me
[s=53] how long have you been on meridia
5 avoid
allergy,
alcohol
Avoid taking cough and cold
or allergy medications while
taking Meridia. Avoid drinking
alcohol while taking Meridia.
[s=108] i may have shared this earlier
was the fact that you have no
desire for alcohol
[s=91] i do not understand your reaction to the
water issue
[s=69] whether i was drinking a sports drink
eating a health food bar or campbell s soup i
was consuming some type of detrimental sugar
6 blood
pressure
dangerously high blood
pressure
[s=143] watch your blood pressure as
some patients have had sharp rises
in their bp
[s=61] and he believes if the blood pressure
elevates at all the patient should be taken off
[s=42] he wanted to wait 6 months and do
another blood test
7 heartbeats fast, pounding, or unevenheartbeats
[s=137] i guess meridia can be hard on
the heart so my doctor wants to be sure
my heart is good
[s=72] they are tracking any unusual symptoms
[s=76] although i would have never considered
myself depressed in the past
8 pain,
headache
chest pain or heavy feeling,
pain spreading to the
arm or shoulder, general
ill feeling, headache,
back pain, joint pain
[s=132] in the beginning i had severe
headaches and insomnia but that went
away within 3 4 days
[s=49] bend the knee of your other leg
and bring that knee up toward your stomach
[s=79] it is really getting me down
and i am an emotional eater so that is not good
9 expensive,
afford
It is expensive, most cannot
afford it. [s=101] it s expensive but worth it
[s=75] i have had no side effects at all
[s=92] the cost is 196
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Table 5.3: The extra outcomes for Meridia without expert comments
ID Extra Opinions
10 [s=372] i wish you luck on meridia
11 [s=276] i started taking it in november 2004 when i weighed in at 325lbs
12 [s=286] it s nice seeing more postings its encourage to know that there are more out
there with lots in common
dr”, or “i have learned to ask my physician questions concerning the particular medication”
which capture the word “dr”, “physician”, the same meaning of “doctor”.
5.4 Evaluation
In this part we would evaluate the effectiveness of our integration system. We design three tasks
of evaluation, aiming to check how well our system-generated results would match human
choices. In the experiment, we choose three volunteers to be the judges, who are from the
major of computer science, nutrition and bioinformatics.
5.4.1 Task 1. Identifying the Extra Outcomes
In this task, we plan to identify the extra outcomes from the outcomes with prior knowledge.
For each drug, we randomly choose 2 assigned sentences from each of the system-generated
outcome clusters (including clusters with prior knowledge and clusters without it). So we
totally have 24 sentences for Meridia and Vioxx, and 18 sentences for Tysabri. All the judges
need to select 6 sentences which do not fit into the clusters with prior knowledge.
Table 5.8 shows how the system recover the human choice. In the table, the coverage rate
refers to the ratio of the number of sentences agreed on by the system and the judge to the total
number (here is 6). It could be seen as a measure of accuracy. For all three drugs, our system
would acquire a relatively high accuracy on average (66.7%, 55.6%, 66.7%)
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Table 5.4: The outcome results for Vioxx with expert comments
ID Keywords Expert comment Similar Opinions Supplementary Opinions
1 reduce
inflam-
mation,
pain
Vioxx works by reducing
substances that cause
inflammation, pain, and
fever in the body. Vioxx
is used to reduce pain,
inflammation
[s=632] hope everyone is not in too
much pain this week i am still hoping
this vioxx will work
[s=470] positive results that reduces
inflammation
[s=363] he said it is a new anti inflammatory
similar to vioxx and it works with narcotic pain
[s=417] i went back to the doctor today
and he gave me vioxx to reduce the
muscle spasms and inflammation
2 doctor di-
rected
Do not take Vioxx without
first talking to your doctor.
Take Vioxx exactly as directed
by your doctor.
[s=816] i called the doctor and he said
the vioxx would not make you feel
this way
[s=470] it was a lot easier to talk to my doctor
than i thoguht it would be
[s=477] i was using it on a regular basis
till i had my follow up labs taken my
liver function
3 taken
dose,
water,
shake
Take each dose with a full
glass of water. Shake the Vioxx
suspension well before
measuring a dose.
[s=701] you will have to consume
approximately the same amount of
vioxx each day and your doctor may
need to adjust
[s=430] during the worse period i had my
doctor even had me on a daily dose cloriquin
[s=478] my gi doc told me it was ok to take
2000mg daily
4 no restric-
tions
There are no restrictions on
food, beverages, or activity
during treatment with Vioxx.
[s=590] as for those medicines that
shouldn t be taken with food, this one
is different.
[s=548] i can eat very little and some of
the foods i can eat
[s=425] i kept a diligent journal of all my
side effects and made sure i was seen by
one of them
5 allergic,
reaction
an allergic reaction (difficulty
breathing; closing of your
throat; swelling of your lips,
tongue, or face; or hives)
[s=520] i get bad reaction to but pain is
worsening and have to find what can
help me
[s=434] no horrible reaction
[s=479] adults who get adverse reactions and
demented from hep
6 heart,
nausea
have congestive heart failure
and heart disease, nausea,
heartburn
[s=526] i was one of the unfortunate
people given double doses of vioxx
for my as and ended up with
heart damage
[s=410] in my experience i have found that
pharmaceutical drugs are too pure
and concentrated causing many unbearable
side effects such as nausea
[s=448]the nausea and diarrhea from
the colchicine was much worse for
me than from the combo
7 pain, dis-
comfort
abdominal pain, tenderness,
or discomfort
[s=702] i have the redness and
inflammation but not constant pain
and tenderness
[s=359] the ulnar pain that you mention that
you have does it feel like when you have hit
your funny bone
[s=424] i also get alot of numb tingly achy
pain up the sides of my
[s=356] when i explained the probs about
my spine he palpated all my vertebrae
and agreed there was definite tenderness
at the two spots
8 liver,
kidney
disease
have liver disease, have kidney
disease
[s=789] even if i didn t have a liver
disease i shouldn t take any other
[s=383] when a person suffers nerve damage
a doctor is supposed to look for a cause
[s=365] the risk that you should most be
concerned with is the possibility of liver
problems which should be monitored by
the doctor
[s=411] in april i had to discontinue my
methotrexate due to elevated liver enzimes
9 aspirin,
affect
aspirin or or an aspirin-like
medication such as salsalate
will affect Vioxx
[s=420] that has touched my pain
besides aspirin which thinned my
blood way too much
[s=482] vitamins i take contain 400mcg
of folate or folic acid
[s=494] c and a good multivitamin will help
you reach your goal sooner rather than later
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Table 5.5: The extra outcomes for Vioxx without expert comments
ID Extra Opinions
10 [s=1337] i moved on to some prescriptions but those have been pulled off the market
vioxx and bextra
11 [s=1377] the vioxx scandal has already taught us how ruthless the pharmaceuticals
can be in pursuit of their profits
12 [s=1703] after all when the commotion about vioxx was going on i didn t give it too
much thought either because i wasn t feeling it myself
Table 5.6: The outcome results for Tysabri with expert comments
ID Keywords Expert comment Similar Opinions Supplementary Opinions
1 immune
system
Tysabri is a monoclonal
antibody that affects the actions
of the body’s immune system.
Monoclonal antibodies are
made to target and destroy only
certain cells in the body.
[s=71] they would like to kill the whole
thing but the immune system is
pretty resilient
[s=36]it sounds the one unfortunate soul
was allergic to one of the antibodies used
and died after an alternative prove too potent
[s=34] i cannot express the estatic feelings
i felt in being able to regain some
of what i lost to ms with tysabri s help
2 doctor
talk
Before taking Tysabri, talk
with your doctor.
[s=53] as for comments from doctors of
tysabri i suggest you contact dr
[s=32] they offered to put me up for the night
but i couldn t stay
[s=34] my doc and i know that many of you
will disagree that tysabri will be available
again as our best fight against this disease
3 infection,
death,
risk, brain
Tysabri may cause a serious
viral infection of the brain
that can lead to disability or
death. This risk is higher if you
have a weak immune system or
are receiving certain medicines.
[s=49] new cases of brain infection
linked to tysabri
[s=26] my neuro called tonight and we had an
extensive conservation about pml tysabri
[s=23] there is not any proof yet that
the combination of medication caused the death
and the near death of these individuals
4 injection,
clinic
Tysabri is injected into a vein
through an IV. You will receive
this injection in a clinic or
hospital setting every 4 weeks.
[s=63] i know that some weeks go by
where i never miss an injection despite
potential obstacles
[[s=31] and the study confirm the safety
profile from previous clinical studies of tysabri
[s=24] after i first started receiving tysabri
everyone noticed how much i had improved
[s=37] he is clinical associate professor of
neurology at the university
5 headache,
depres-
sion
headache, tired feeling,
depression
[s=61] side effects headache around
1 to 2 hours after but gone later
that night
[s=43] these fractures may go undiagnosed for
years
[s=26] i can tell you that when i am fatigued
around am on muggy july mornings
i am sad about it
6 joint pain joint or muscle pain; stomachpain, diarrhea
[s=42] many people have fractures and
it s a leading cause of low back and
leg pain
[s=30] has tysabri eliminated her ms and all
its damage
[s=31] however i am not discouraged in the
least because i could stand today
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Table 5.7: The extra outcomes for Tysabri without expert comments
ID Extra Opinions
7 [s=146] the agency s removal of clinical hold could pave the way for re entry of
tysabri to the marketplace
8 [s=126] it seems to me that tysabri needs to achieve to not lose us money is 11-14
market share
9 [s=165] access to tysabri is currently limited to ongoing clinical trials due to product
availability
Table 5.8: Task 1 result
Coverage rate Meridia Vioxx Tysabri
Judge1 4/6=66.7% 4/6=66.7% 4/6=66.7%
Judge2 4/6=66.7% 3/6=50% 4/6=66.7%
Judge3 4/6=66.7% 3/6=50% 4/6=66.7%
Average 66.7% 55.6% 66.7%
5.4.2 Task 2. Classifying the Outcomes with Expert Comments
In the second task, we aim to evaluate the effectiveness of our system in grouping sentences
into m outcome clusters with prior knowledge. For each drug, we still choose 2 sentences from
each of the system-generated outcome clusters (only the clusters with prior knowledge). All
the judges are asked to assign each sentence to one of the m groups (for Meridia and Vioxx,
m = 9, for Tysabri, m = 6).
Table 5.9: Task 2 result
Coverage rate Meridia Vioxx Tysabri
Judge1 12/18=66.7% 13/18=72.2% 9/12=75%
Judge2 15/18=83.3% 10/18=55.6% 10/12=83.3%
Judge3 16/18=88.9% 13/18=72.2% 12/12=100%
Average 79.6% 66.7% 86.1%
Agreement rate 9/18=50% 10/18=55.6% 8/12=66.7%
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The results are shown in Table 5.9. From the last row, we know that three judges agree on
50%, 55.6%, 66.7% of the sentences about the class labels, respectively, which indicates that
the classification is a subjective work – the results are controversial even among human judges.
Even such a subjective task, our system shows a high match with the human opinions. (e.g.,
the coverage rate of Tysabri is 86.1%).
5.4.3 Task 3. Distinguishing Similar Opinions and Supplementary
Opinions
The third task tries to explore how well we can separate the similar opinions from the supple-
mentary ones. For each drug, we choose 4 outcome clusters and for each cluster i, we choose
1 sentence from Oi sim, mixed with 2 sentences from Oi sup. The judges are asked to pick up
the most similar one with the expert comment from three.
Table 5.10: Task 3 result
Coverage rate Meridia Vioxx Tysabri
Judge1 4/4=100% 3/4=75% 3/4=75%
Judge2 4/4=100% 3/4=75% 3/4=75%
Judge3 4/4=100% 2/4=50% 3/4=100%
Average 100% 66.7% 75%
The results are shown in Table 5.10. The high accuracy shows that our method can suc-
cessfully recognize the semantic difference among the sentences in one outcome cluster.
5.4.4 Limitation of PLSA
From the results we observe that Vioxx always has the lowest accuracy among three. A poten-
tial reason would be its oversize clusters may affect the quantity. PLSA model requires to set
the number of clusters manually and lacks a way to dynamically determine the proper number
of clusters. We would try to solve the problem in the future work.
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5.5 Labeling Result
Following the methods described in Section 4.3, for three drugs, we automatically generate
top 3 semantic labels for each similar opinion Oi sim, as well as the extra outcome without
expert comments, Table 5.11 shows the overall results. (Extra outcomes: OID 10 − 12 for
Meridia/Vioxx, 7 − 9 for Tysabri). We can see most of the labels are not only understandable
but also reflect the meaning of the corresponding cluster. And we also find that the labels for
the extra outcomes either discuss the extra topic, or does not make sense since too scattered.
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Table 5.11: Label results
OID Top3 labels
1 lost pounds, 4 lbs, 8 pounds
2 private doctor, toxicity ones, the prescription
3 x1 daily, units daily, picolinate 500mg
4 seven years, point not, 2 years
5 suit against, minimally impact, alcohol allergic
6 bloody pressure, consistent normal, tiredness dizzness
7 caused heart, beat fast, developing ischemic
8 arms back, relief pain, joint pain
9 price high, worth of, size 1
10 willing to, support good, experience them
11 started new, go after, worried about
12 loving it, stimulant treatment, few questions
(a). Meridia
OID Top3 labels
1 reducing inflammation, probably caused, pain reduced
2 refer him, visit doctor, ask ahead
3 400mg tablet, msm 400mg, take aggressively
4 cooked food, meat fresh, contributing factor
5 arthus reaction, supportive help, bad reaction
6 heart problem, anixety attack, physiological treatment
7 abdominal pain, neuropathic pain, classic symptom
8 liver problem, not taken, meds pain
9 besides aspirin, cure yourself, proton pump
10 out market, against vioxx, market bextra
11 patients from, training me, the tremors
12 not interested, surgery you, treatment hope
(b). Vioxx
OID Top3 labels
1 flu symptoms, weakened immune, body enervation
2 doctor call, doctor prescription, matter process
3 calculated risk, greater risk, sudden death
4 intramuscular injection, dominant medicine, receive training
5 heavy feeling, extremely tired, muscle ache
6 instant pain, arm pain, spasticity problems
7 prior review, get approved, rule breaker
8 los angeles, senior citizens, transgression although
9 undisclosed november, appointment september, august 9
(c). Tysabri
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CHAPTER 6
Conclusion
In this paper, we build a useful system to filter, integrate and label drug-based medical infor-
mation. SVM-classifier, semi-supervised PLSA model and automatic labeling techniques are
applied in the system. The experiment results with high accuracy show that our system can
successfully reorganize the online medical information in a readable and understandable way.
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CHAPTER 7
Future Work
In the future, we will focusing on the following potential directions:
1. In this paper, we take three drugs: Meridia, Vioxx, Tysabri as examples since they are the
FDA-withdrawn drugs with serious side efforts. In this case, the task is relatively easy –
the user comments would talk a lot about the side efforts which can be distinguished as
outcomes from all the sentences. When it comes to the routine drugs, or even treatments,
the clusters would be less discriminative. We will try build a web-based comprehensive
system to show the outcomes and detailed opinions of each drug (withdrawn, routine)
and treatment.
2. Other online sources also contain much information about personal health messages,
e.g., Twitter 1. Twitter contains not only many users’ comments but also the network
relationships. We can apply network analysis on the current system and develop new
topics: cluster content evolving analysis; content-based popularity analysis, etc.
3. PECO pattern mining from the extracted results. This would be helpful to label PECO
sentences from the medical literatures and informal messages automatically.
4. As Section 5.4 discussed, PLSA model requires to set the number of clusters manually
and lacks a way to dynamically determine the proper number of clusters. We would
focus on how to automatically decide the number of the semantic clusters instead of a
1http://twitter.com/
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fixed number. A combination of multiple clustering methods can be applied to achieve
such goal.
5. In this paper, we utilize a straightforward labeling method which lacks the semantic
analysis. In the future, we would enhance the labeling method by enroll first-order rel-
evance [13], which would capture the sematic meaning better. Also good labels would
offer more accurate prior knowledge to create new clusters for new outcomes, which are
not specified by an expert, but discovered automatically by the system.
6. Speech-based reorganization and detection. In Theorell’s work [19], mobile device can
be used to record health diaries by patients’ voice. How to transfer speech into text,
recognize and segment the useful information are all challenging and promising topics.
Based on the current progress and plan, we could build solid work to extend this topic
and publish some qualified conference/journal papers. It can be a promising PhD thesis in the
future.
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